| Code | 4168E | ||||||||||
| MA number | EU/1/18/1323/004 | ||||||||||
| Product Form: | sol inj 1x1 ml/100 mg (pero napl.) | ||||||||||
| MA Status: | E - Valid centralised marketing authorisation | ||||||||||
| Type of procedure: | EU | ||||||||||
| MAH, country: | Almirall, S.A., Spain | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Subcutaneous use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 8(3) application - new active substance |
| MA issued: | 17.09.2018 |
| Safety feature | Yes |
| Data update: | 16.08.2023 |
